T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Cytek Biosciences
CTKB
$636M
| $212K | ﹤0.01% |
24,744
+3,210
| +15% | +$28.8K |
|
|
MITT
2502
TPG Mortgage Investment Trust
MITT
$214M
| $212K | ﹤0.01% |
34,500
| – | – |
|
2503
Spruce Power Holding Corp
SPRU
$33.6M
| $212K | ﹤0.01% |
32,638
| – | – |
|
2504
Willdan Group
WLDN
$1.29B
| $212K | ﹤0.01% |
11,034
+89
| +0.8% | +$1.5K |
|
2505
Argan
AGX
$7.84B
| $210K | ﹤0.01% |
5,321
+181
| +4% | +$7.32K |
|
2506
America Movil
AMX
$69.8B
| $210K | ﹤0.01% |
9,700
| – | – |
|
2507
Employers Holdings
EIG
$871M
| $209K | ﹤0.01% |
5,569
+442
| +9% | +$17.3K |
|
|
NXRT
2508
NexPoint Residential Trust
NXRT
$636M
| $209K | ﹤0.01% |
+4,586
| New | +$198K |
|
2509
Rimini Street
RMNI
$470M
| $209K | ﹤0.01% |
43,435
+451
| +1% | +$1.87K |
|
2510
LSB Industries
LXU
$711M
| $208K | ﹤0.01% |
21,037
-2,720
| -11% | -$26K |
|
2511
Ribbon Communications
RBBN
$377M
| $208K | ﹤0.01% |
74,256
+4,185
| +6% | +$11.6K |
|
|
NVTA
2512
DELISTED
Invitae Corporation
NVTA
| $208K | ﹤0.01% |
183,354
-43,635
| -19% | -$55K |
|
|
ACR
2513
ACRES Commercial Realty
ACR
$101M
| $206K | ﹤0.01% |
23,265
| – | – |
|
2514
PUT
Norwegian Cruise Line
NCLH
$8.98B
| $205K | ﹤0.01% |
+9,400
| New | +$144K |
|
2515
Designer Brands
DBI
$312M
| $204K | ﹤0.01% |
20,170
-2,292
| -10% | -$18.9K |
|
2516
Emergent Biosolutions
EBS
$230M
| $204K | ﹤0.01% |
27,690
+4,059
| +17% | +$37.6K |
|
2517
FB Financial Corp
FBK
$3.1B
| $204K | ﹤0.01% |
7,251
-73,536
| -91% | -$2.09M |
|
2518
Hyliion Holdings
HYLN
$734M
| $203K | ﹤0.01% |
121,468
+3,724
| +3% | +$6.28K |
|
|
TSVT
2519
DELISTED
2seventy bio
TSVT
| $202K | ﹤0.01% |
19,928
-586,826
| -97% | -$6.21M |
|
|
ARIS
2520
DELISTED
Aris Water Solutions
ARIS
| $201K | ﹤0.01% |
+19,395
| New | +$168K |
|
2521
Crescent Energy
CRGY
$3.93B
| $201K | ﹤0.01% |
19,277
+642
| +3% | +$6.88K |
|
|
PLYM
2522
DELISTED
Plymouth Industrial REIT
PLYM
| $201K | ﹤0.01% |
+8,701
| New | +$186K |
|
2523
Energy Fuels
UUUU
$3.64B
| $201K | ﹤0.01% |
32,112
+2,874
| +10% | +$16.9K |
|
2524
Wave Life Sciences
WVE
$1.02B
| $201K | ﹤0.01% |
55,167
+18,608
| +51% | +$75.2K |
|
2525
Dutch Bros
BROS
$8.93B
| $200K | ﹤0.01% |
7,000
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.